Royalty Pharma plc
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Jun 2019 | — | 71.6% | 33.2% |
| Sep 2019 | — | 114.7% | 88.1% |
| Mar 2020 | — | 72.2% | 14.2% |
| Jun 2020 | — | 80.1% | 86.5% |
| Sep 2020 | — | 94.8% | 54.0% |
| Dec 2020 | — | 54.9% | 137.5% |
| Mar 2021 | — | 40.0% | 12.1% |
| Jun 2021 | — | 134.2% | 79.4% |
| Sep 2021 | — | 51.7% | 17.4% |
| Dec 2021 | — | 26.6% | 1.4% |
| Mar 2022 | — | 39.1% | 9.2% |
| Jun 2022 | — | 70.5% | 56.8% |
| Sep 2022 | — | 33.5% | 24.9% |
| Dec 2022 | — | -85.3% | -80.6% |
| Mar 2023 | — | 70.0% | 49.8% |
| Jun 2023 | — | 46.2% | 42.3% |
| Sep 2023 | — | 28.2% | 13.4% |
| Dec 2023 | — | 102.8% | 82.9% |
| Mar 2024 | — | -13.0% | 0.8% |
| Jun 2024 | — | 50.2% | 19.0% |
| Sep 2024 | — | 130.2% | 96.3% |
| Dec 2024 | — | 60.9% | 35.1% |
| Mar 2025 | — | 94.0% | 42.1% |
| Jun 2025 | — | 36.3% | 5.6% |
| Sep 2025 | — | 70.1% | 47.3% |
| Dec 2025 | — | 62.4% | 34.0% |
| Mar 2026 | — | 89.3% | 46.7% |
| Jun 2026 | — | 19.7% | 2.7% |